| 2-AGE | noladin ether |
| Abn-CBD | abnormal-cannabidiol |
| APCA | arachidonylcyclopropylamide |
| ARA-S | arachidonoyl-L-serine |
| CB1,2-R | cannabinoid receptor types 1 and 2 |
| CBD | cannabidiol |
| CBRs | cannabinoid receptors |
| DAGL-α,β | diacylglycerol lipases α,β |
| DHEA | docosahexaenoyl ethanolamid |
| DEA | docosatetraenoyl ethanolamide |
| ECS | endocannabinoid system |
| EDH | endothelium-dependent hyperpolarization |
| EPEA | eicosapentaenoyl ethanolamide |
| ERAs | endothelin receptor antagonists |
| HEA | homo-γ-linolenyl ethanolamide |
| hPAs | human pulmonary arteries |
| LEA | inolenoyl ethanolamide |
| 2-LG | linoleoylglycerol |
| LPI L | alpha-Lysophosphatidylinositol |
| MCT | monocrotaline |
| MethAEA | methanandamide |
| NAGly N | arachidonoyl glycine |
| ODA | oleamide |
| OEA | oleoyl ethanolamide |
| PAH | pulmonary arterial hypertension |
| POEA | palmitoleoyl ethanolamide |
| PAP | pulmonary arterial pressure |
| PASMCs | pulmonary artery smooth muscle cells |
| PEA | ethanolamide |
| PH | pulmonary hypertension |
| PPAR-γ | peroxisome proliferator-activated receptor-γ |
| PVR | pulmonary vascular resistance |
| rPA | rat pulmonary artery |
| RVSP | right ventricular systolic pressure |
| SEA | stearoyl ethanolamide |
| U46619 | analogue of thromboxane A2 |
| VIR | virodhamine |